Transcriptomic Signature Development
Transcriptomic Signature Development is the systematic process of identifying and validating a set of gene expression patterns that uniquely characterize a specific biological state or condition, distinguishing it from other molecular profiling approaches by focusing on reproducible, interpretable, and clinically or functionally relevant transcriptional markers.
102
Publications
6.9K
Citations
1.4K
Authors
540
Institutions
Publications per year
2017–2026
77
Parents
102
Transcriptomic dissection of tongue squamous cell carcinoma
Hui Ye, Tianwei Yu, Stéphane Temam et al. · BMC Genomics · 2008 · 344 citations · Full text
Medicine, Cancer Biology, Oncology +11
Bénédicte Gaborit, Nicolas Venteclef, Patricia Ancel et al. · Cardiovascular Research · 2015 · 232 citations · Full text
1–5 of 102
1.4K
5
h-index
5
h-index
5
h-index
4
h-index
4
h-index
1–5 of 1.4K
540
Inserm
Paris, France
16 h-index
156 publications
7.9K citations

Centre National de la Recherche Scientifique
Paris, France
10 h-index
77 publications
3.8K citations
Assistance Publique – Hôpitaux de Paris
Paris, France
9 h-index
29 publications
2.7K citations
Harvard University
Cambridge, United States
8 h-index
34 publications
1.8K citations
Aix-Marseille Université
Marseille, France
7 h-index
53 publications
3.4K citations
Université Paris Cité
Paris, France
7 h-index
16 publications
868 citations
City of Hope
Lancaster, United States
6 h-index
15 publications
1.1K citations

Brigham and Women's Hospital
Boston, United States
6 h-index
15 publications
1.6K citations
1–8 of 540
5 publications · 256 citations
5
h-index
5 publications · 196 citations
5
h-index
2 publications · 71 citations
2
h-index
2 publications · 88 citations
2
h-index
2 publications · 63 citations
2
h-index
1–5